Susquehanna International Group
ROIV icon

Susquehanna International Group’s Roivant Sciences ROIV Stock Holding History

Susquehanna International Group’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.69M Sell
277,700
-408,700
-60% -$10.5M ﹤0.01% 3514
2025
Q4 		$14.9M Sell
686,400
-179,300
-21% -$3.54M ﹤0.01% 2549
2025
Q3 		$13.1M Buy
865,700
+437,700
+102% +$5.42M ﹤0.01% 2691
2025
Q2 		$4.82M Buy
428,000
+31,700
+8% +$344K ﹤0.01% 4032
2025
Q1 		$4M Buy
396,300
+6,000
+2% +$64.9K ﹤0.01% 4076
2024
Q4 		$4.62M Sell
390,300
-101,800
-21% -$1.2M ﹤0.01% 3722
2024
Q3 		$5.68M Sell
492,100
-79,800
-14% -$909K ﹤0.01% 3400
2024
Q2 		$6.04M Sell
571,900
-19,600
-3% -$215K ﹤0.01% 3149
2024
Q1 		$6.23M Sell
591,500
-243,000
-29% -$2.62M ﹤0.01% 3286
2023
Q4 		$9.37M Buy
834,500
+659,600
+377% +$6.43M ﹤0.01% 2721
2023
Q3 		$2.04M Buy
174,900
+86,400
+98% +$977K ﹤0.01% 5092
2023
Q2 		$892K Buy
88,500
+59,400
+204% +$531K ﹤0.01% 6963
2023
Q1 		$215K Buy
29,100
+8,500
+41% +$70K ﹤0.01% 10449
2022
Q4 		$165K Sell
20,600
-5,600
-21% -$31.2K ﹤0.01% 10387
2022
Q3 		$84K Sell
26,200
-23,900
-48% -$92.5K ﹤0.01% 11844
2022
Q2 		$204K Buy
50,100
+15,500
+45% +$61.5K ﹤0.01% 10588
2022
Q1 		$171K Buy
+34,600
New +$228K ﹤0.01% 11426

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group's ROIV Position: Q1 2026 in Review

Susquehanna International Group reduced its Roivant Sciences (ROIV) stake by 85% in Q1 2026, selling an estimated $28M and leaving 196,195 shares worth $5.43M. The position accounts for ﹤0.01% of the portfolio, ranked #4087.

Susquehanna International Group first reported a position in ROIV in Q4 2021 and has held it in 17 quarters since. The position peaked at $27.9M in Q4 2025. 441 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • Susquehanna International Group held 196,195 shares of Roivant Sciences worth $5.43M as of Q1 2026.
  • Susquehanna International Group sold 1,090,002 Roivant Sciences shares in Q1 2026, an estimated $28M.
  • Roivant Sciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4087 holding.
  • Susquehanna International Group first reported a position in Roivant Sciences in Q4 2021 and has held it in 17 quarters since.
  • Susquehanna International Group's Roivant Sciences position peaked at $27.9M in Q4 2025.
  • 441 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.